'The pinnacle of human health': What it takes to be a super pooper
BBC/ Emmanuel LafontPoo transplants are on the rise, but less than 3% of us produce a product that is worthy of donation. Even fewer are super poopers. This is the search for the fairest stool of all.
In 2013, Adam Faye found himself wondering what kind of dinner would make for the highest quality poo.
At the time, Faye was a fourth-year medical student learning how to treat Clostridioides difficile, a bacterial infection that causes severe gastrointestinal issues and is naturally resistant to many antibiotics. One elderly patient was suffering from serious, recurring infections. She needed a faecal transplant.
This pioneering procedure would add another person's poo directly into her colon, introducing a healthier community of microorganisms into her gut. These would then hopefully out-compete the C. difficile and restore balance. But where to get the poo from? There weren't many stool banks around at the time, and the patient's family and friends weren't able or willing to donate.
So, Faye stepped up.
The night before the big day, Faye settled on a burrito for dinner. The next morning, in his student housing, he defecated into a pink medical-grade basin. Then, he filtered the results through cotton gauze with a salt solution, draining it into a bottle. "I remember I put it in a paper bag, because I was walking around with this bottle of murky water," he says.
A couple of hours later, Faye's poo was sprayed inside the patient's guts during a colonoscopy. Faye, now a gastroenterologist at NYU Langone Health in New York, later found out that the procedure had worked. The patient never had a C. difficile infection again.
In the years since, research on the gut microbiome's role in health has skyrocketed. With that, there is increasing interest in poo transplants, or faecal microbota transplants (FMTs). The transplants are already approved to treat C. difficile, and they're being trialled worldwide for conditions including irritable bowel syndrome, diabetes, autism and osteoporosis. There is even interest in using them to treat cognitive decline and mental illnesses.
Faecal transplants can be delivered directly into someone's gut or given orally, with poo that has been encapsulated into a pill. But finding people whose poo is worthy of being used for these purposes is no easy task. The screening process is fastidious, and only the healthiest candidates are deemed suitable donors. The very best poo – from donors colloquially dubbed 'super poopers' – is even harder to come by.
For this story, I asked six stool banks and laboratories to interview their donors. They all said that it's so hard to find reliable donors that they can't risk invading their privacy and having them back out. So, who are these elite defecators, and how can science find the perfect poo?
The poopers
The screening process for a stool donor is never universal. It varies depending on what condition the poo is being used to treat. But it is extremely thorough.
"We'd be looking for an individual that's the pinnacle of human health, and screening them the way we would an organ donor," says Carl Crawford, a gastroenterologist at Weill Cornell Medicine in New York. They put the donor through the wringer, just as they would with someone donating a kidney or blood, he says.
To become a stool donor, one must first complete several health surveys and interviews, along with detailed blood and stool tests to screen for infectious diseases. The list can include more than 30 pathogens, parasites, and multidrug-resistant organisms. Some clinics even require testing for Covid-19 and the flu.
That's because many infectious diseases can be passed through poo. In some cases, FMT has accidentally caused transmission of E.coli. Some respiratory infections including Covid-19 can even be transmitted via poo particles that become airborne when you flush the toilet.
Donors are also screened for their history of certain health conditions, such as some autoimmune disorders or mental health problems.
Some laboratories scrutinise medications and supplements taken by potential donors, including multivitamins and iron. "We really question that and see if it's possible for them to stop taking it," says Susan Poutanen, a medical microbiologist at the University of Toronto. Donors there also record whether they've eaten common allergens in the prior week. "Sometimes we need nut-free poo."
Donors usually fit within the age range of 18 to 48. But anybody can receive the transplant. "We have treated 17-year-olds, and we've treated 96-year-olds," says Susy Hota, an infectious disease expert at the University of Toronto, who performs faecal transplants.
While most stool programs do not explicitly assess the diets of their donors, ideally they would eat a relatively healthily, with lots of fibre. Fruits, vegetables and whole grains tend to give the gut microbiome the right ingredients to flourish. "One would think that donors should be vegetarian, but those that have an omnivorous diet seem to have a greater biodiversity in their gastrointestinal tract," says Crawford.
When possible, donors should also be lean, say Hota and Poutanen. In one case, a 32-year-old woman who was previously slim became obese after receiving a stool donation from a healthy but overweight donor. Many other factors, from alcohol consumption to exercise and sleep, are also considered. There can even be strict travel restrictions, in case donors inadvertently pick up drug-resistant gut bacteria.
Though Crawford no longer sources faeces for transplants himself, he says that in his experience around 3% of people pass the initial screening. About half of those are then considered to have the right balance of bacteria for regular donation.
For Hota in Toronto, only around 1.6% of potential donors make it through the initial screening. Around 0.6% are retained as regular donors.
Getty ImagesBut the scientists who run stool banks or research programs note that the logistical and practical requirements of being a stool donor are absolutely not to be underestimated. Faye's case, a one-time donation for a patient he knew, is not common.
If you are one of the rare stool donors who passes screening, you're likely to be invited to join a program for regular pooping. The routine entails going into the laboratory almost every day to poo in a designated donor toilet.
Many stool banks pay donors. In the US, for example, rewards can range from $25 (£19) per donation to around $100 (£76). Each stool bank has donors they use repeatedly, as it's more efficient than finding new ones each time.
"The relationship with the donors is something I find fascinating," says Hota. She explains that you have to build trust while respecting their autonomy. For example, patients are often asked to disclose any minor lifestyle changes.
Prepping the stool
To prepare poo samples for transplantation, Elizabeth Hohmann, a researcher and physician at Massachusetts General Hospital, first blends a slurry of poop. "Horrible thought, I know," she says. Then, it is filtered through five layers of extremely fine meshes, which she purchases from brewing manufacturers. She then separates the poo and dissolves it in a salty solution, before freezing the sample. Studies show they're best delivered to the patient fresh.
The super poopers
These initial screens and tests can still only predict so much.
The poo of any qualifying donor has an equal chance of successfully treating recurrent C. difficile infections. However, when it comes to certain conditions, research suggests that the faeces of some special donors leads to significantly higher rates of remission compared to others.
For instance, in one 2015 study testing faecal transplants for ulcerative colitis, a type of bowel disease, only nine people out of 38 went into remission. Seven of those had poo from the same donor.
Another study from 2017 involved mixing together faeces from up to seven donors for transplantation. Those who received a mix containing some from one special donor were around twice as likely to feel better than those who received a mix without it. But it's not clear what made this crème de la crème of stool so effective.
Full microbiome tests during stool donation are not routine. But research has revealed that super poopers tend to have an abundance of gut bacteria and a wide variety of them. Their faeces also tend to include species known to be beneficial, such as Faecalibacterium prausnitzii. This species produces the fatty acid butyrate, which has a number of useful functions such as reducing inflammation and protecting the lining of the intestines.
Even then, no one's poo is a silver bullet. The ideal donor for C. difficile might have no impact on someone with, say, IBS or depression, says Faye. "We're still trying to figure out what is the secret sauce," he says.
"Oh, I'm sure that a 'super pooper' exists," says Hohmann. Scientists just don't have any reliable tests that can find them yet, in part because there's no reliable definition of what a super poo is, she says.
Beyond looking for the perfect poop, a growing body of research suggests that matching patients with compatible stool donors may be a more promising approach. Scientists could classify donors and patients into categories, based on factors such as the variety of their gut microbes.
From poo to pills
Even with the finest product from the most effective super-poopers, faecal transplants are far from an exact science.
"My biggest reservation is probably the unpredictability of FMT," says Sara Benterkia, from Queen Mary University of London. "You're transferring a whole microbial community, so there are many variables to consider." Different donors, preparations and recipients can produce very different microbial changes.
Crawford, meanwhile, says that the transplants could be a stepping stone to more standardised treatments. For example, the company Ferring Pharmaceuticals produces REBYOTA, an enema product from the poo of donors with an abundance of beneficial bacteria. Seres Therapeutics produces VOWST pills containing certain bacterial spores, also manufactured from human poo. Both are FDA approved for the treatment of recurrent C. difficile infection.
More like this:
In fact, Crawford says the future of treating C. difficile infection is likely to involve pills of microbes that have been handpicked from good donors and then grown at scale in a lab. "I think that microbiome-based therapies have the potential to be the future of medicine," he says.
However, the future of harnessing our microbiomes also leaves Crawford anxious, given how heavily modern life manipulates our natural microbiome. For example, ultra processed foods are known to reduce the diversity of the gut microbiome.
"I worry that we may lose the properties of a lot of the organisms that are inside of our gastrointestinal tracts that can help us fight the next wave of diseases," says Crawford. He compares the potential healing power within the gut to the abundance of helpful plant-derived chemicals that have been discovered within tropical rainforests. "The microbiome inside of our GI tract is much more vast and can help us just as well. We just take it for granted."
* All content within this article is provided for general information only, and should not be treated as a substitute for the medical advice of health care professionals.
--
For trusted insights on health and wellbeing, sign up to the Health Fix newsletter by senior health correspondent Melissa Hogenboom who also writes the Live Well For Longer and Six Steps to Calm courses.
